Houston Startup Vapogenix Aims to Build a Better Pain Drug

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Treating pain usually means taking medication that has to course through our bloodstream—our entire body—before it can take effect. The thing is, we typically feel pain in one place. So why can’t we just treat that specific area, and in a faster fashion? Houston-based Vapogenix is working on a drug that could do exactly that. “Our core drug goes through skin in five minutes,” says Danguole Altman, Vapogenix’s president and CEO. The base drug of Vapogenix’s drug are the liquid anesthetics—Altman doesn’t want to get into specific drug names for proprietary reasons—which are vaporized by anesthesiologists for use on patients during surgery. Vapogenix’s innovation, she says, is reformulating those drugs into a topical analgesic, either a patch or a liquid, that can be applied directly on to the skin.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC